Stock screenerAll disclosures →
EDGAR →
RNA
Conviction 20HealthcareScan · Thu, Jun 25, 2026RNA$12.80-0.23%
ResistanceSupportVol 14Vol MA14 239.01K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price12.80
Change-0.23%
Gap+0.39%
Rel volume3.64×
Avg volume233.95K
Avg $ vol2.94M
SMA 2012.46
SMA 5012.95
SMA 20043.22
Price vs 50-1.17%
Price vs 200-70.38%
MA stackbearish
50/200 cross—
Supertrenddown · 13.23
RSI (14)50
MACD hist0.15
MACD crossbull · 9d
Stoch %K / %D80 / 81
ADX (14)15
+DI / −DI21 / 14
RSI divergence—
MACD divergence—
ATR %+3.90%
ADR %4.17%
52w high72.93
52w low11.55
From 52w high-82.45%
Above 52w low+10.82%
New 52w highNo
SqueezeOff
Bollinger width15.13%
%B0.68
Donchian pos51.13%
Donchian high14.14
Donchian low11.40
AVWAP (52w high)47.59
vs AVWAP high-73.11%
AVWAP (52w low)12.66
vs AVWAP low+1.13%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d3.64×
Avg vol (14d)239.01K
Avg vol (20d)233.95K
Avg $ vol (20d)2.94M
Market cap218.95M
RS 3m (vs SPY)-15.06%
RS 6m (vs SPY)-90.61%
RS line new highNo
Trend template0/8
Technical rank16.9
1 week+2.56%
1 month-1.99%
3 months-2.22%
6 months-82.31%
1 year-56.09%
YTD-82.25%
P/E—
P/B0.94
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current13.04
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-48.9M
Revenue19.64M
Net income-16.63M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out17.11M
Employees391
ListedFri, Feb 27, 2026
Free float16.24M
Float %94.9%
Short interest3.65M
Days to cover15.8d
Short volume44.7%
Squeeze score83 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank16.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance14.05
Support11.80
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RNA
No recent disclosed trades by Congress in RNA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RNA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kenney Stephanie See Remarks · Common Stock · 2026-04-20 | Grant | 30K | $0 | 2026-04-20 | 2026-04-22 |
Hughes Steven George Chief Medical Officer · Stock Option (Right to Buy) · 2026-04-20 | Grant | 60K | $0 | 2026-04-20 | 2026-04-22 |
Kenney Stephanie See Remarks · Stock Option (Right to Buy) · 2026-04-20 | Grant | 60K | $0 | 2026-04-20 | 2026-04-22 |
Hoyos Rocio Martin Chief Strategy Officer · Common Stock · 2026-04-20 | Grant | 30K | $0 | 2026-04-20 | 2026-04-22 |
Winslow Brendan R. Chief Financial Officer · Common Stock · 2026-04-20 | Grant | 30K | $0 | 2026-04-20 | 2026-04-22 |
Gallagher Kathleen P. See Remarks · Stock Option (Right to Buy) · 2026-04-20 | Grant | 205K | $0 | 2026-04-20 | 2026-04-22 |
Hughes Steven George Chief Medical Officer · Common Stock · 2026-04-20 | Grant | 30K | $0 | 2026-04-20 | 2026-04-22 |
Winslow Brendan R. Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-20 | Grant | 60K | $0 | 2026-04-20 | 2026-04-22 |
Gallagher Kathleen P. See Remarks · Common Stock · 2026-04-20 | Grant | 102.5K | $0 | 2026-04-20 | 2026-04-22 |
Hoyos Rocio Martin Chief Strategy Officer · Stock Option (Right to Buy) · 2026-04-20 | Grant | 60K | $0 | 2026-04-20 | 2026-04-22 |
SEC filings
EDGAR filings in RNA
No recent SEC filings on file for RNA.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.